Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0UNL stock hub

LON/0UNL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0UNLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0UNL

In the news

Latest news · LON/0UNL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-53.6

P25 -54.2P50 2.1P75 13.7

ROIC-173.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0UNL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

166

Groups with data

Currency

USD

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	63
Employees Change	2%
Employees Change Percent	3.28
Enterprise value	$1.6B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US6402683063
Last refreshed	2026-05-10
Market cap	$2B
Price	$81.68
Price currency	USD
Rev Per Employee	668,748.4x
Sector	Healthcare
Sic	2834
Symbol	lon/0UNL
Website	https://www.nektar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.9%
EV Earnings	-13.33x
EV/Sales	39.1x
P/B ratio	4.65x
P/S ratio	48.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-224.08%
EBITDA Margin	-222.54%
Gross margin	100%
Gross Profit	$42.1M
Gross Profit Growth	-14.54%
Gross Profit Growth Q	3.83%
Gross Profit Growth3 Y	-5.27%
Gross Profit Growth5 Y	-11.86%
Net Income	$-119.7M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-284.41%
Profit Margin	-284.18%
Profit Per Employee	$-1.9M
ROA	-15.28
Roa5y	-20.76
ROCE	-17.67
ROE	-53.6
Roe5y	-116.6
ROIC	-173.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	552.47%
Cagr3y	88.55%
Cagr5y	-21.65%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-36.24x
Revenue Growth Q	3.83x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-14.44x
Revenue Growth5 Y	-15.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.11
Assets	$578M
Cash	$430.6M
Current Assets	$432.1M
Current Liabilities	$42.3M
Debt	$108.6M
Debt Equity	$0.25
Equity	$436.4M
Interest Coverage	-4.28
Liabilities	$141.7M
Long Term Assets	$146M
Long Term Liabilities	$99.3M
Net Cash	$445.4M
Net Cash By Market Cap	$21.97
Net Cash Growth	1,630.3%
Net Debt Equity	$-1.02
Tangible Book Value	$436.4M
Tangible Book Value Per Share	$17.64
WACC	11.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.21
Net Working Capital	$-11.2M
Quick ratio	9.85
Working Capital	$402.4M
Working Capital Turnover	$0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	551.63%
200-day SMA	54.77
3Y total return	570.61%
50-day SMA	77.88
50-day SMA vs 200-day SMA	50over200
5Y total return	-70.48%
All Time High	1,027.4
All Time High Change	-92.05%
All Time High Date	2018-09-05
All Time Low	6.53
All Time Low Change	1,151.8%
All Time Low Date	2023-11-13
ATR	5.2
Beta	1.25
Ch YTD	94.11
High	85
High52	109
High52 Date	2026-04-20
High52ch	-25.07%
Low	80
Low52	21.09
Low52 Date	2025-08-01
Low52ch	287.38%
Ma50ch	4.89%
Price vs 200-day SMA	49.14%
RSI	48.27
RSI Monthly	61.8
RSI Weekly	63.79
Sharpe ratio	1.79x
Sortino ratio	5.51
Total Return	-39.76%
Tr YTD	94.11
Tr1m	6.99%
Tr1w	-5.94%
Tr3m	120.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-94.4M
Operating margin	-224.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,651,829%
Shares Insiders	0.39%
Shares Institutions	63.36%
Shares Qo Q	21.87%
Shares Yo Y	39.76%
Short Ratio	2.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,350.8x
Bv Per Share	17.64
Ch1m	6.99
Ch1w	-5.94
Ch1y	551.6
Ch3m	120.7
Ch3y	570.6
Ch5y	-70.48
Ch6m	45.38
Change	-0.98%
Change From Open	0.53
Close	82.49
Days Gap	-1.5
Depreciation Amortization	628,254.7
Dollar Volume	101,773.3
Earnings Date	2026-05-07
EBIT	$-94.4M
EBITDA	$-93.8M
EPS	$-6.13
F Score	3
Fiscal Year End	December
Founded	1,990
Income Tax	$-95,420
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-06-09
Last Split Type	Reverse
Ma150	61.27
Ma150ch	33.31%
Ma20	86.62
Ma20ch	-5.7%
Open	81.25
Position In Range	33.6
Price Date	2026-05-08
Ptbv Ratio	4.65
Relative Volume	0.38x
Revenue	42,131,149x
Tax By Revenue	-0.23x
Tr6m	45.38%
Volume	1,246
Z Score	-3.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0UNL pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0UNL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0UNL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.4%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0UNL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.3

Neutral momentum band

Price vs 200-day MA

+49.1%

50/200-day relationship not available

Beta (5Y)

1.25

More volatile than the market

Sharpe ratio

1.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0UNL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0UNL stock rating?

lon/0UNL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0UNL analysis?

The full report lives at /stocks/lon/0UNL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0UNL?

The latest report frames lon/0UNL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0UNL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.